A study of circulating anti-CD25 antibodies in non-small cell lung cancer

L Ye; X Li; S Sun; S Guan; M Wang; X Guan; K-H Lee; J Wei; B Liu

doi:10.1007/s12094-012-0980-2

A study of circulating anti-CD25 antibodies in non-small cell lung cancer

L Ye
, X Li
, S Sun
, S Guan
, M Wang
, X Guan
, K-H Lee
, J Wei
, B Liu

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

Original language	English
Pages (from-to)	633-7
Number of pages	5
Journal	Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Volume	15
Issue number	8
DOIs	https://doi.org/10.1007/s12094-012-0980-2
Publication status	Published - Aug 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12094-012-0980-2

Cite this

Ye, L., Li, X., Sun, S., Guan, S., Wang, M., Guan, X., Lee, K.-H., Wei, J., & Liu, B. (2013). A study of circulating anti-CD25 antibodies in non-small cell lung cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 15(8), 633-7. https://doi.org/10.1007/s12094-012-0980-2

@article{2b606b9114434f008339ff53a87cf3d7,

title = "A study of circulating anti-CD25 antibodies in non-small cell lung cancer",

abstract = "Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.",

author = "L Ye and X Li and S Sun and S Guan and M Wang and X Guan and K-H Lee and J Wei and B Liu",

year = "2013",

month = aug,

doi = "10.1007/s12094-012-0980-2",

language = "English",

volume = "15",

pages = "633--7",

journal = "Clinical \& Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico",

issn = "1699-3055",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "8",

}

Ye, L, Li, X, Sun, S, Guan, S, Wang, M, Guan, X, Lee, K-H, Wei, J & Liu, B 2013, 'A study of circulating anti-CD25 antibodies in non-small cell lung cancer', Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 15, no. 8, pp. 633-7. https://doi.org/10.1007/s12094-012-0980-2

TY - JOUR

T1 - A study of circulating anti-CD25 antibodies in non-small cell lung cancer

AU - Ye, L

AU - Li, X

AU - Sun, S

AU - Guan, S

AU - Wang, M

AU - Guan, X

AU - Lee, K-H

AU - Wei, J

AU - Liu, B

PY - 2013/8

Y1 - 2013/8

N2 - Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

AB - Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.

U2 - 10.1007/s12094-012-0980-2

DO - 10.1007/s12094-012-0980-2

M3 - Article

C2 - 23263913

SN - 1699-3055

VL - 15

SP - 633

EP - 637

JO - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

JF - Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

IS - 8

ER -

A study of circulating anti-CD25 antibodies in non-small cell lung cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this